Ruby CY Lin profile

Ruby CY Lin

Website Linkedin Twitter

I help organisations build academic-industry hybrid teams. I am interested in implementing genomic (personalised) medicine into healthcare and translate research outcomes into clinical settings. My publications are available in ORCID (0000-0003-4163-511X), Google Scholar and Research Gate (>5300 citations). 

I have a BSc in Zoology and MSc (1st Class Hons) in Molecular and Cellular Biology from the University of Canterbury, New Zealand, and a PhD in Medicine (Molecular Genetics) from the University of Sydney, Australia. I was a named NHMRC Peter Doherty Fellow (2005-8) and then a University of NSW Vice-Chancellor Global Research Fellow (2009-2014). I have secured over $6.4 million AUD competitive Category 1 research funding (including several NHMRC project grants, ARC LIEF) in the discipline of cardiovascular diseases, obesity, cancer biology, biobanking, infectious diseases and phage therapy.

I advocate for women in STEMM and do pro bono career coaching. I am a mentor for the Junior Science Academy holiday program at Macquarie University and I volunteer in activities such as primary ethics in my kids primary school education journey.

Building a sustainable ecosystem for phage therapy cover
October 10, 2022
Building a sustainable ecosystem for phage therapy
PhageBusiness ModelsSustainability
News | August 31, 2022
Phage Therapy
Natural virus predators offer potential alternative to antibiotics
Academics plan to roll out therapy widely in Australia: Researchers at the University of Sydney, Western Sydney Local Health District and the Westmead Institute for Medical Research are developing a therapeutic solution to antimicrobial resistance that predates the discovery and wide usage of antibiotics… [Link to Paper](https://www.escmid.org/fileadmin/src/media/PDFs/1Dates_Events/event_flyers/ESGNTA_Course22_web.pdf)
News | August 17, 2022
Phage Therapy
A therapy from the past could hold the key to beating antibiotic resistance in the future
An expert team, led by Director of the Centre of Infectious Diseases and Microbiology at the Westmead Institute for Medical Research (WIMR) Professor Jon Iredell, is developing a key alternative to antibiotics and central to the treatment are phages…
Publication | February, 2021
Phage TherapyCliniciansReview paper

A Phage Therapy Guide for Clinicians and Basic Scientists: Background and Highlighting Applications for Developing Countries

Frontiers in Microbiology
Authors: Ali Khalid, Ruby C. Y. Lin and Jonathan R. Iredell
Publication | January, 2020
AbstractPhage Therapy

Bacteriophage therapy in the critically ill

Australian Critical Care
Authors: Josephine Ho, Aleksandra Petrovic Fabijan, Ruby CY. Lin, Susan Maddocks, Jonathan Iredell
Publication | April, 2021
Phage biobankOpinion paper

Phage Biobank: Present Challenges and Future Perspectives

Current Opinions in Biotechnology
Authors: Ruby CY Lin, Jessica C Sacher, Pieter-Jan Ceyssens, Jan Zheng, Ali Khalid, Jonathan R Iredell, The Australian Phage Biobanking Network.
Publication | November, 2020
PediatricsPhage TherapyClinical trialResearch paper

Therapeutic monitoring of the host-bacterium-phage interaction in a child

Research Square | Pre-print
Authors: Ameneh Khatami, Ruby Lin, Aleksandra Petrovic-Fabijan, Sivan Alkalay-Oren, Sulaiman Almuzam, Philip Britton, Michael Brownstein, Quang Dao, Joseph Fackler, Ronen Hazan, Bri’Anna Horne, Ran Nir-Paz, Jonathan Iredell
Publication | March, 2019
Phage TherapyResearch paper

Bacteriophage therapy for severe infections

Microbiology Australia
Authors: Carola Venturini, Aleksandra Petrovic Fabjian and Ruby CY Lin
Publication | August, 2021
Clinical trialPediatricsImmune responsePhage Therapy

Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child

EMBO Molecular Medicine
Authors: Ameneh Khatami, Ruby C Y Lin, Aleksandra Petrovic-Fabijan, Sivan Alkalay-Oren, Sulaiman Almuzam, Philip N Britton, Michael J Brownstein, Quang Dao, Joe Fackler, Ronen Hazan, Bri’Anna Horne, Ran Nir-Paz, Jonathan R Iredell
Publication | December, 2020
Phage VirulenceAntibiotic synergyResearch paper

Rapid automated system for bacteriophage virulence and antibiotic synergy testing – The ‘phago-antibiogram’

International Journal of Infectious Diseases
Authors: A. Khalid, A.P. Fabijan, S. Maddocks, R.C.Y. Lin J.R. Iredell
Publication | April, 2020
Review paperPhage Therapy

Phage therapy for severe bacterial infections: a narrative review

The Medical Journal of Australia
Authors: Aleksandra Petrovic Fabijan, Ali Khalid, Susan Maddocks, Josephine Ho, Timothy Gilbey, Indy Sandaradura, Ruby CY Lin, Nouri Ben Zakour, Carola Venturini, Bethany Bowring, Jonathan R Iredell
Phage Australia logo

Phage Australia is a national network of phage researchers and clinician scientists who aim to professionalise phage therapy as the third major intervention for infectious diseases, after vaccines and antibiotics.

We acknowledge the traditional custodians of the First Nation, whose culture and customs have nurtured and continue to nurture this land, since the Dreamtime. We pay our respects to Elders past, present and emerging and celebrate the diversity of Aboriginal peoples and their ongoing cultures and connections to the lands and waters of Australia

Resources
Sequence your phages
Request phage therapy
Media / Press Kit
Glossary
Grant Appendix
info@phageaustralia.org @phageaustralia Linkedin
© 2023 Phage Australia